Physician profile
Michael T Barger
NPI 1124125208
$2,663.33
in general payments reported to CMS, 2019-2025
13 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,648 · 2020: $662 · 2021: $213 · 2022: $140.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $732.91 | 2019-2022 | |
| Amgen INC. | $484.59 | 2019 | |
| Abbvie INC. | $441.75 | 2019-2020 | |
| Genzyme Corporation | $219.86 | 2019 | |
| Pfizer INC. | $168.25 | 2019-2020 | |
| Janssen Scientific Affairs, LLC | $124.99 | 2019 | |
| Genentech USA, INC. | $124.13 | 2019 | |
| Radius Health, INC. | $104.01 | 2020 | |
| Sanofi-Aventis U.S. LLC | $90.58 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $81.10 | 2019 | |
| Glaxosmithkline, LLC. | $52.55 | 2019 | |
| Janssen Biotech, INC. | $21.72 | 2019 | |
| Aurinia Pharma U.S., INC. | $16.89 | 2022 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Barger listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.